Jennifer Fox obtained her Ph.D. in Biochemistry, Molecular and Cell Biology from Cornell University. Following a post-doctoral fellowship in the Genome Instability Section of the Genetics and Molecular Biology Branch at the National Human Genome Research Institute (NHGRI), she moved to the National Center for Advancing Translational Sciences (NCATS) where she was involved in the discovery and development of small molecule probes and drug leads for the treatment of neurological disorders and cancer. Dr. Fox continued her work in drug development as a scientist in the Human Therapeutics Division at Intrexon Corporation before joining the NCI’s Division of Cancer Prevention’s Chemopreventative Agent Development Research Group in 2017. At NCI, she served as a Contracting Officer’s Representative (COR) for the PREVENT Cancer Preclinical Drug Development Program, where she oversaw task orders testing the preventive efficacy of novel chemical entities and repurposed drugs in small animal models of cancer. Dr. Fox joined NIA’s Division of Aging Biology in the Biological Resources Branch in December 2021.